Acumen Pharmaceuticals Inc (ABOS)
US$ 1.45-0.68%
Price Chart
Key Statistics
Market Cap
$ 90.25M
P/E Ratio
0.00
Revenue (TTM)
$ 329K
Volume
161.34K
52W High
$ 3.60
52W Low
$ 0.85
Dividend Yield
0.00%
Beta
0.05
Technicals
50-Day MA
1.1207
200-Day MA
1.649
52 Week High
3.6
52 Week Low
0.855
About ABOS
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease.
Employees
61
Headquarters
Newton, MA
CEO
Mr. Daniel J. O'Connell M.B.A.
Latest News
$ABOS stock is up 11% today. Here's what we see in our data. - Quiver Quantitative
4 days ago • Google News
Abo’s Coney Island deli opens in Albany - Times Union
2025-02-12 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg